Duchenne Care UK podcast series launched

On World Duchenne Awareness Day 2026, we are pleased to share the launch of the Duchenne Care UK podcast series, supporting the goal of delivering consistent, high-quality care across the UK. The series is based on the Duchenne Care UK Patient and Family Guides, and...

Duchenne Care UK orthopaedic guideline recognised by NICE

We are pleased to share that NICE has recognised another clinical guideline published as part of the Duchenne Care UK national programme that we fund. NICE (the National Institute for Health and Care Excellence) has reviewed Duchenne Care UK’s recommendations on...

Solid doses first patient on Phase 3 trial

Today, Solid Biosciences announced that the first participant has been dosed in the Phase 3 Impact Duchenne clinical trial, a randomised, double-blind, placebo-controlled study evaluating SGT-003 for Duchenne. Clinical trial sites are currently active in Australia and...
Duchenne Care UK launches psychosocial guidelines

Duchenne Care UK launches psychosocial guidelines

We are delighted to share that psychosocial guidelines for Duchenne muscular dystrophy have been published by Duchenne Care UK. We are proud to be a key funder of the psychosocial programme, which is part of a wider, multi‑year national effort by Duchenne Care UK to...

Solid announces positive clinical update

Solid Biosciences has announced a positive clinical update on the SGT-003 gene therapy programme. This update includes interim safety and biomarker data from the ongoing Phase 1/2 Inspire Duchenne clinical trial. To date, 40 participants have been dosed with SGT-003...
Duchenne Care UK launches psychosocial guidelines

Duchenne Care UK strives for best care for all at national meeting

The pychosocial working group gathered around Duchenne Care UK’s newly published education guidelines for teachers. Pictured from left: Duchenne Care UK project coordinator Adam Kerr; Pathfinders advocacy officer Sam Cornelius-Light; consultant child and...

DMD Care UK respiratory guideline recognised by NICE

The Duchenne Research Fund is delighted to share that NICE has recognised the respiratory care guidelines that were created and published by the DMD Care UK programme that we fund. This follows NICE’s recognition of DMD Care UK’s cardiac guidelines in...

Solid shares update on Inspire Duchenne clinical trial

Solid Biosciences has released an update on its Inspire Duchenne clinical trial, which is investigating the safety, tolerability and efficacy of its gene therapy candidate SGT-003. The Phase 1/2, open-label study has now dosed 23 patients, and expects to have dosed 30...

DMD Care UK cardiac guideline recognised by NICE

On World Duchenne Awareness Day 2025, the Duchenne Research Fund is delighted to share that NICE has recognised the cardiac care guidelines that were created and published by the DMD Care UK programme that we fund. As stated on NICE’s website: “We think...

DMD Care UK publishes annual meeting report

DMD Care UK has published a report following its national meeting earlier this year, sharing insights into the success of its workshops and knowledge sharing. More than 80 clinical professionals attended in person, and there were more than 170 dial-ins to online...